Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Cash from Operations (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Cash from Operations for 16 consecutive years, with 15744000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Cash from Operations fell 2668.35% year-over-year to 15744000.0, compared with a TTM value of 16100000.0 through Jun 2025, down 1810.95%, and an annual FY2023 reading of 97000.0, up 100.47% over the prior year.
  • Cash from Operations was 15744000.0 for Q2 2025 at SRx Health Solutions, down from 384000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1463000.0 in Q4 2024 and bottomed at 15744000.0 in Q2 2025.
  • Average Cash from Operations over 5 years is 2711500.0, with a median of 2264000.0 recorded in 2021.
  • The sharpest move saw Cash from Operations surged 159.75% in 2024, then crashed 2668.35% in 2025.
  • Year by year, Cash from Operations stood at 3538000.0 in 2021, then increased by 27.05% to 2581000.0 in 2022, then soared by 138.4% to 991000.0 in 2023, then skyrocketed by 47.63% to 1463000.0 in 2024, then tumbled by 1176.14% to 15744000.0 in 2025.
  • Business Quant data shows Cash from Operations for SRXH at 15744000.0 in Q2 2025, 384000.0 in Q1 2025, and 1463000.0 in Q4 2024.